SEC Company Response from EXOZYMES (EXOZ) — Jan 22, 2026
EXOZYMES INC.
Date: Jan. 22, 2026 · CIK: 0002010788 · Accession: 0001493152-26-003204
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-292781
Letter
Exozymes Inc.
Royal Oaks Drive, Suite 106
Monrovia, CA 91016
(626) 415-1488
January 22, 2026
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
F Street N.E.
Washington, D.C. 20549
Re: Exozymes Inc.
Registration Statement on Form S-3, File No. 333- 292781
REQUEST FOR ACCELERATION OF EFFECTIVENESS
Requested Date: January 23, 2026
Requested Time: 4:30 pm, Eastern Time
Ladies and Gentlemen:
Exozymes Inc. (the "Company") hereby requests that the effective date of the Company's Registration Statement on Form S-3 (File No. 333-292781) be accelerated pursuant to Rule 461 under the Securities Act of 1933, as amended, so that it will be declared and become effective at 4:30 p.m. Eastern time on January 23, 2026, or as soon thereafter as possible, or at such later time as the Company may orally request via telephone call to the staff of the Commission (the "Staff"). The Company hereby authorizes Andrew D. Hudders of Golenbock Eiseman Assor Bell & Peskoe, LLP, counsel to the Company, to make such request on its behalf.
Please contact our counsel, Andrew D. Hudders of Golenbock Eiseman Assor Bell & Peskoe LLP, on (212) 907-7349, with any questions you may have regarding this request. In addition, the Company requests that you kindly notify Mr. Hudders by telephone when this request for acceleration has been granted.
Sincerely
yours,
/S/
Michael Heltzen
Show Raw Text
CORRESP 1 filename1.htm Exozymes Inc. 750 Royal Oaks Drive, Suite 106 Monrovia, CA 91016 (626) 415-1488 January 22, 2026 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street N.E. Washington, D.C. 20549 Re: Exozymes Inc. Registration Statement on Form S-3, File No. 333- 292781 REQUEST FOR ACCELERATION OF EFFECTIVENESS Requested Date: January 23, 2026 Requested Time: 4:30 pm, Eastern Time Ladies and Gentlemen: Exozymes Inc. (the "Company") hereby requests that the effective date of the Company's Registration Statement on Form S-3 (File No. 333-292781) be accelerated pursuant to Rule 461 under the Securities Act of 1933, as amended, so that it will be declared and become effective at 4:30 p.m. Eastern time on January 23, 2026, or as soon thereafter as possible, or at such later time as the Company may orally request via telephone call to the staff of the Commission (the "Staff"). The Company hereby authorizes Andrew D. Hudders of Golenbock Eiseman Assor Bell & Peskoe, LLP, counsel to the Company, to make such request on its behalf. Please contact our counsel, Andrew D. Hudders of Golenbock Eiseman Assor Bell & Peskoe LLP, on (212) 907-7349, with any questions you may have regarding this request. In addition, the Company requests that you kindly notify Mr. Hudders by telephone when this request for acceleration has been granted. Sincerely yours, /S/ Michael Heltzen Michael Heltzen Chief Executive Officer